Acelyrin Inc. (SLRN)
undefined
undefined%
At close: undefined
3.21
-0.47%
After-hours Dec 13, 2024, 04:42 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
Revenue - - -
Cost of Revenue 115.00K - -
Gross Profit -115.00K - -
Operating Income -422.06M -254.68M -41.79M
Interest Income 30.55M 4.17M -
Pretax Income -381.64M -250.46M -41.84M
Net Income -381.64M -250.46M -41.84M
Selling & General & Admin 66.18M 24.05M 3.56M
Research & Development 355.89M 230.63M 38.23M
Other Expenses - -132.00K -45.00K
Operating Expenses 422.06M 254.68M 41.79M
Interest Expense - - -
Selling & Marketing Expenses - - -
Cost & Expenses 422.06M 254.68M 41.79M
Income Tax - -4.17M -41.79K
Shares Outstanding (Basic) 70.25M 20.44M 20.44M
Shares Outstanding (Diluted) 70.25M 20.44M 20.44M
EPS (Basic) -5.43 -12.25 -2.05
EPS (Diluted) -5.43 -12.25 -2.05
EBITDA -381.53M -64.77M -41.84M
Depreciation & Amortization 115.00K 69.18K 41.79K